We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+8.87%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$1.12B
AUM Growth
+$138M
Cap. Flow
+$55.5M
Cap. Flow %
4.96%
Top 10 Hldgs %
42.4%
Holding
337
New
15
Increased
66
Reduced
104
Closed
33

Sector Composition

Rank Sector Weight
1 Healthcare 12.97%
2 Financials 11.35%
3 Energy 8.62%
4 Real Estate 6.49%
5 Technology 5.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
176
iShares Core S&P 500 ETF
IVV
$904B
$556K 0.05%
1,721
+3
+0.2% +$928
NUE icon
177
Nucor
NUE
$63B
$545K 0.05%
9,681
-380
-4% -$20.7K
TAK icon
178
Takeda Pharmaceutical
TAK
$56.3B
$535K 0.05%
27,122
-26,322
-49% -$504K
DOW icon
179
Dow Inc
DOW
$22.5B
$531K 0.05%
9,702
-137,666
-93% -$7.11M
WMT icon
180
Walmart Inc
WMT
$900B
$530K 0.05%
13,371
-429
-3% -$17K
SON icon
181
Sonoco
SON
$5.74B
$512K 0.05%
8,300
BKR icon
182
Baker Hughes
BKR
$63.7B
$502K 0.04%
19,600
GMF icon
183
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$439M
$500K 0.04%
4,833
-1,018
-17% -$100K
IRWD icon
184
Ironwood Pharmaceuticals
IRWD
$692M
$497K 0.04%
37,355
-140,100
-79% -$1.54M
VDE icon
185
Vanguard Energy ETF
VDE
$10.3B
$489K 0.04%
6,000
WBA
186
DELISTED
Walgreens Boots Alliance
WBA
$489K 0.04%
8,300
IWR icon
187
iShares Russell Mid-Cap ETF
IWR
$57.7B
$481K 0.04%
8,061
IONS icon
188
Ionis Pharmaceuticals
IONS
$9.48B
$468K 0.04%
7,740
-260
-3% -$15.5K
LCTX icon
189
Lineage Cell Therapeutics
LCTX
$283M
$466K 0.04%
523,756
-170,100
-25% -$142K
IBB icon
190
iShares Biotechnology ETF
IBB
$9.86B
$449K 0.04%
3,725
KBWB icon
191
Invesco KBW Bank ETF
KBWB
$6.79B
$449K 0.04%
7,715
-584
-7% -$32.2K
REGN icon
192
Regeneron Pharmaceuticals
REGN
$83.8B
$446K 0.04%
1,187
-15
-1% -$5.05K
SGEN
193
DELISTED
Seagen Inc. Common Stock
SGEN
$446K 0.04%
3,900
XEC
194
DELISTED
CIMAREX ENERGY CO
XEC
$433K 0.04%
8,250
RTX icon
195
RTX Corp
RTX
$302B
$432K 0.04%
4,586
-3,704
-45% -$336K
IXN icon
196
iShares Global Tech ETF
IXN
$9.2B
$426K 0.04%
12,156
+54
+0.4% +$1.77K
ARES icon
197
Ares Management
ARES
$31.9B
$424K 0.04%
11,889
+139
+1% +$4.32K
MGM icon
198
MGM Resorts International
MGM
$10.9B
$424K 0.04%
12,750
-71
-0.6% -$2.16K
IPAY icon
199
Amplify Mobile Payments ETF
IPAY
$181M
$423K 0.04%
8,525
+1,522
+22% +$72.4K
FLOT icon
200
iShares Floating Rate Bond ETF
FLOT
$10.5B
$422K 0.04%
8,284
+66
+0.8% +$3.36K

Similar funds

Northeast Financial Consultants's Q4 2019 Portfolio in Review

As of Q4 2019, Northeast Financial Consultants held 337 positions worth $1.12B, up 14% from $981M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Northeast Financial Consultants deployed $55.5M of net new capital in Q4 2019, opening 15 new positions and adding to 66 existing holdings. Its largest new stake was Broadmark Realty Capital Inc. Common Stock: 3,117,112 shares worth $39.7M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Dow Inc, an estimated $7.11M trimmed.

  • Northeast Financial Consultants's largest Q4 2019 buy was Broadmark Realty Capital Inc. Common Stock: 3,117,112 shares worth $39.7M.
  • Northeast Financial Consultants added most to Pfizer in Q4 2019, an estimated $30.1M increase.
  • Northeast Financial Consultants's biggest Q4 2019 reduction was Dow Inc, cutting an estimated $7.11M.
  • Northeast Financial Consultants fully exited Brown-Forman Class B in Q4 2019, selling an estimated $3.85M.
  • Northeast Financial Consultants's ten largest holdings make up 42% of its $1.12B portfolio in Q4 2019.
  • Northeast Financial Consultants opened 15 new positions and closed 33 in Q4 2019.
  • Northeast Financial Consultants's portfolio value rose 14% quarter-over-quarter to $1.12B.

Based on Northeast Financial Consultants's 13F filing for Q4 2019, filed 14 Feb 2020.